Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,131 | 1,169 | 3,214 | 4,966 | 5,010 |
| Receivables | 375 | 448 | 443 | 288 | 437 |
| TOTAL | $1,506 | $1,617 | $3,657 | $5,254 | $5,447 |
| Non-Current Assets | |||||
| PPE Net | 8,497 | 9,686 | 10,180 | 10,671 | 10,825 |
| Other Non-Current Assets | 1,837 | 958 | 1,014 | 1,126 | 1,200 |
| TOTAL | $10,334 | $10,644 | $11,194 | $11,797 | $12,025 |
| Total Assets | $11,840 | $12,261 | $14,851 | $17,051 | $17,472 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,623 | 1,028 | 1,308 | 1,538 | 1,384 |
| TOTAL | $2,120 | $1,392 | $1,672 | $1,925 | $1,780 |
| Non-Current Liabilities | |||||
| Long Term Debt | 293 | 280 | 19,820 | 19,510 | 19,368 |
| Other Non-Current Liabilities | 1,569 | 586 | 643 | 732 | 893 |
| TOTAL | $1,862 | $866 | $20,463 | $20,242 | $20,261 |
| Total Liabilities | $3,982 | $2,258 | $22,135 | $22,167 | $22,041 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 464 |
| Retained earnings | -121,673 | -115,309 | -126,816 | -124,494 | -122,335 |
| Other shareholders' equity | -1,740 | -1,740 | -1,740 | -1,740 | -1,740 |
| TOTAL | $7,858 | $10,003 | $-7,284 | $-5,116 | $-4,569 |
| Total Liabilities And Equity | $11,840 | $12,261 | $14,851 | $17,051 | $17,472 |